Natural products have long been a valuable source of anticancer leads. β-lapachone (β-Lap), a natural naphthoquinone compound, has been shown to be a promising anticancer candidate, although its low solubility and bioavailability limit its direct application in the clinic. Boron nitride nanocages have emerged as potential nanocarriers for drug delivery due to their high stability and biocompatibility. Here, we employed density functional theory (DFT) to evaluate the potential of transition metal (M = Fe, Co, Ni, Cu, Zn)-doped nanocage B
36N
36 as a drug carrier for β-Lap delivery. Our results indicated that β-Lap interacts with the B
![]()
N bonds of the nanocage through its C
![]()
O group(s). The incorporation of metals effectively enhances the β-Lap adsorption characteristics of B
36N
36. The encapsulation of metals inside B
36N
36 was found to be the most stable structure, and the adsorption energy of β-Lap on metal-encapsulated B
36N
36 (except for Zn) was found to be higher than that on B
36N
36 in both aqueous and vacuum states. The electron density difference (EDD), spin density, and frontier molecular orbital theory demonstrate electron transfer from metal dopants to C
![]()
O groups of β-Lap, weakening C
![]()
O bonds while strengthening C
![]()
C bonds to stabilize the complex, with metal doping significantly enhancing adsorption efficiency. Atoms-in-molecules (AIM) theory further reveals that metal doping reinforces O
![]()
B bonds formed between β-Lap and B
36N
36 into stronger coordination bonds. The independent gradient model based on Hirschfeld division (IGMH) analysis visually confirms the spatial distribution of interaction regions within the system. Overall, Zn-(1) and Fe-(3) doped B
36N
36 are expected to be promising candidates for delivering β-Lap, with recovery times at body temperature of 26.44 s and 248 s, respectively. This work provides
in silico support for further development of metal-doped B
36N
36 nanocage as a drug delivery system.